Mechanism of Cistanches Herba in treatment of cancer-related fatigue based on network pharmacology and experimental verification.
10.19540/j.cnki.cjcmm.20221201.701
- Author:
Shi-Lei ZHANG
1
;
Jia-Li LIU
2
;
Fu-Kai GONG
3
;
Jian-Hua YANG
4
;
Jun-Ping HU
2
Author Information
1. School of Pharmacy, Xinjiang Medical University Urumqi 830011, China School of Public Health, Xinjiang Medical University Urumqi 830011, China.
2. School of Pharmacy, Xinjiang Medical University Urumqi 830011, China.
3. Department of Pharmacy, Xinjiang Uygur Autonomous Region People's Hospital Urumqi 830001, Xinjiang, China.
4. School of Pharmacy, Xinjiang Medical University Urumqi 830011, China Department of Pharmacy, the First Affiliated Hospital of Xinjiang Medical University Urumqi 830054, China.
- Publication Type:Journal Article
- Keywords:
Cistanches Herba;
cancer-related fatigue;
experimental verification;
mechanism;
network pharmacology
- MeSH:
Animals;
Mice;
Cistanche;
Network Pharmacology;
Beclin-1;
Reactive Oxygen Species;
Plant Extracts;
Drugs, Chinese Herbal/pharmacology*;
Molecular Docking Simulation;
Medicine, Chinese Traditional;
Neoplasms/genetics*
- From:
China Journal of Chinese Materia Medica
2023;48(5):1330-1342
- CountryChina
- Language:Chinese
-
Abstract:
This study aimed to explore the mechanism of Cistanches Herba in the treatment of cancer-induced fatigue(CRF) by network pharmacology combined with in vivo and in vitro experiments to provide a theoretical basis for the clinical medication. The chemical constituents and targets of Cistanches Herba were searched from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP). The targets of CRF were screened out by GeneCards and NCBI. The common targets of traditional Chinese medicine and disease were selected to construct a protein-protein interaction(PPI) network, followed by Gene Ontology(GO) functional and Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway enrichment analyses. A visual signal pathway rela-ted to Chinese medicine and disease targets was constructed. The CRF model was induced by paclitaxel(PTX) in mice. Mice were divided into a control group, a PTX model group, and low-and high-dose Cistanches Herba extract groups(250 and 500 mg·kg~(-1)). The anti-CRF effect in mice was evaluated by open field test, tail suspension test, and exhaustive swimming time, and the pathological morphology of skeletal muscle was evaluated by hematoxylin-eosin(HE) staining. The cancer cachexia model in C2C12 muscle cells was induced by C26 co-culture, and the cells were divided into a control group, a conditioned medium model group, and low-, medium-, and high-dose Cistanches Herba extract groups(62.5, 125, and 250 μg·mL~(-1)). The reactive oxygen species(ROS) content in each group was detected by flow cytometry, and the intracellular mitochondrial status was evaluated by transmission electron microscopy. The protein expression levels of hypoxia-inducible factor-1α(HIF-1α), BNIP3L, and Beclin-1 were detected by Western blot. Six effective constituents were screened out from Cistanches Herba. The core genes of Cistanches Herba in treating CRF were AKT1, IL-6, VEGFA, CASP3, JUN, EGFR, MYC, EGF, MAPK1, PTGS2, MMP9, IL-1B, FOS, and IL10, and the pathways related to CRF were AGE-RAGE and HIF-1α. Through GO enrichment analysis, it was found that the main biological functions involved were lipid peroxidation, nutrient deficiency, chemical stress, oxidative stress, oxygen content, and other biological processes. The results of the in vivo experiment showed that Cistanches Herba extract could significantly improve skeletal muscle atrophy in mice to relieve CRF. The in vitro experiment showed that Cistanches Herba extract could significantly reduce the content of intracellular ROS, the percentage of mitochondrial fragmentation, and the protein expression of Beclin-1 and increase the number of autophagosomes and the protein expression of HIF-1α and BNIP3L. Cistanches Herba showed a good anti-CRF effect, and its mechanism may be related to the key target proteins in the HIF-1α signaling pathway.
